Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypocretin/Orexin Regulation of Dopamine Signaling and Cocaine Self-Administration Is Mediated Predominantly by Hypocretin Receptor 1
Courtney D. Prince, Andrew R. Rau, Jordan T. Yorgason, et al.
ACS Chemical Neuroscience (2014) Vol. 6, Iss. 1, pp. 138-146
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?
Morgan H. James, Stephen V. Mahler, David E. Moorman, et al.
Current topics in behavioral neurosciences (2016), pp. 247-281
Closed Access | Times Cited: 169
The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases
Chunmei Wang, Qinqin Wang, Bingyuan Ji, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 163
The hypocretin (orexin) system: from a neural circuitry perspective
Shi‐Bin Li, Luı́s de Lecea
Neuropharmacology (2020) Vol. 167, pp. 107993-107993
Closed Access | Times Cited: 111
Orexins and stress
Laura A. Grafe, Seema Bhatnagar
Frontiers in Neuroendocrinology (2018) Vol. 51, pp. 132-145
Open Access | Times Cited: 106
Methamphetamine addiction: involvement of CREB and neuroinflammatory signaling pathways
Irina N. Krasnova, Zuzana Justinová, Jean Lud Cadet
Psychopharmacology (2016) Vol. 233, Iss. 10, pp. 1945-1962
Open Access | Times Cited: 93
Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
Ying Han, Kai Yuan, Yongbo Zheng, et al.
Neuroscience Bulletin (2019) Vol. 36, Iss. 4, pp. 432-448
Open Access | Times Cited: 77
Lateral Hypothalamic Control of the Ventral Tegmental Area: Reward Evaluation and the Driving of Motivated Behavior
Susan M. Tyree, Luı́s de Lecea
Frontiers in Systems Neuroscience (2017) Vol. 11
Open Access | Times Cited: 82
Individual differences in orexin‐I receptor modulation of motivation for the opioid remifentanil
Kirsten A. Porter‐Stransky, Brandon S. Bentzley, Gary Aston‐Jones
Addiction Biology (2015) Vol. 22, Iss. 2, pp. 303-317
Open Access | Times Cited: 74
Suvorexant, an orexin/hypocretin receptor antagonist, attenuates motivational and hedonic properties of cocaine
Taylor A. Gentile, Steven J. Simmons, David J. Barker, et al.
Addiction Biology (2017) Vol. 23, Iss. 1, pp. 247-255
Open Access | Times Cited: 70
Intermittent self‐administration of fentanyl induces a multifaceted addiction state associated with persistent changes in the orexin system
Jennifer E. Fragale, Morgan H. James, Gary Aston‐Jones
Addiction Biology (2020) Vol. 26, Iss. 3
Open Access | Times Cited: 65
Effects of Suvorexant, a Dual Orexin/Hypocretin Receptor Antagonist, on Impulsive Behavior Associated with Cocaine
Taylor A. Gentile, Steven J. Simmons, Mia N. Watson, et al.
Neuropsychopharmacology (2017) Vol. 43, Iss. 5, pp. 1001-1009
Open Access | Times Cited: 64
Sleep dysregulation in binge eating disorder and “food addiction”: the orexin (hypocretin) system as a potential neurobiological link
Jacqueline B. Mehr, Deborah Mitchison, Hannah E. Bowrey, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 12, pp. 2051-2061
Open Access | Times Cited: 46
Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies
Marc Ten-Blanco, África Flores, Luigia Cristino, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101066-101066
Open Access | Times Cited: 19
Hypocretins, Neural Systems, Physiology, and Psychiatric Disorders
Shi‐Bin Li, Jeff R. Jones, Luı́s de Lecea
Current Psychiatry Reports (2016) Vol. 18, Iss. 1
Closed Access | Times Cited: 60
Orexin/Hypocretin System: Role in Food and Drug Overconsumption
Jessica R. Barson, Sarah F. Leibowitz
International review of neurobiology (2017), pp. 199-237
Open Access | Times Cited: 56
Recent advances in understanding the roles of hypocretin/orexin in arousal, affect, and motivation
Natalie Nevárez, Luı́s de Lecea
F1000Research (2018) Vol. 7, pp. 1421-1421
Open Access | Times Cited: 56
Therapeutics development for addiction: Orexin-1 receptor antagonists
David A. Perrey, Yanan Zhang
Brain Research (2018) Vol. 1731, pp. 145922-145922
Open Access | Times Cited: 55
Gene Expression Profiling with Cre-Conditional Pseudorabies Virus Reveals a Subset of Midbrain Neurons That Participate in Reward Circuitry
Lisa E. Pomeranz, Mats I. Ekstrand, Kaamashri N. Latcha, et al.
Journal of Neuroscience (2017) Vol. 37, Iss. 15, pp. 4128-4144
Open Access | Times Cited: 53
DARK Classics in Chemical Neuroscience: Cathinone-Derived Psychostimulants
Steven J. Simmons, Jonna M. Leyrer‐Jackson, Chicora F. Oliver, et al.
ACS Chemical Neuroscience (2018) Vol. 9, Iss. 10, pp. 2379-2394
Open Access | Times Cited: 49
Differential Roles of Each Orexin Receptor Signaling in Obesity
Miyo Kakizaki, Yousuke Tsuneoka, Kenkichi Takase, et al.
iScience (2019) Vol. 20, pp. 1-13
Open Access | Times Cited: 46
The number of lateral hypothalamus orexin/hypocretin neurons contributes to individual differences in cocaine demand
Caroline B. Pantazis, Morgan H. James, Brandon S. Bentzley, et al.
Addiction Biology (2019) Vol. 25, Iss. 4
Open Access | Times Cited: 44
Understanding the Role of Orexin Neuropeptides in Drug Addiction: Preclinical Studies and Translational Value
Alessandra Matzeu, Rémi Martin‐Fardon
Frontiers in Behavioral Neuroscience (2022) Vol. 15
Open Access | Times Cited: 26
Hypocretin receptor 1 blockade preferentially reduces high effort responding for cocaine without promoting sleep
Zachary D. Brodnik, David L. Bernstein, Courtney D. Prince, et al.
Behavioural Brain Research (2015) Vol. 291, pp. 377-384
Open Access | Times Cited: 46
Neuromodulation for the treatment of eating disorders and obesity
Darrin J. Lee, Gavin J.B. Elias, Andrés M. Lozano
Therapeutic Advances in Psychopharmacology (2017) Vol. 8, Iss. 2, pp. 73-92
Open Access | Times Cited: 45
Knockdown of hypocretin attenuates extended access of cocaine self-administration in rats
Brooke E. Schmeichel, Alessandra Matzeu, Pascale Koebel, et al.
Neuropsychopharmacology (2018) Vol. 43, Iss. 12, pp. 2373-2382
Open Access | Times Cited: 41
Page 1 - Next Page

Scroll to top